Free Newsletter
Adult stem cell prototype on the horizon
Shinya Yamanaka, one of Japan's leading stem cell scientists, says he believes he is just months away from developing a prototype stem cell that could substitute for an embryonic stem cell in research. In two or three years, he adds in an interview with The Times of London, stem cells will probably be available which are indistinguishable from an embryonic stem cell, effectively eliminating the need to use embryonic stem cells for research. Yamanaka is credited with a major breakthrough in the field for his work in manipulating the skin cells of mice back to an embryonic stage. If he successfully completes his work, the new procedure would eliminate the controversy over the use of ESCs. But Yamanaka also insists that ESC research should continue for now in the hopes of saving lives, rather than wait to see if his work is ultimately successful.
- read the article from The Times
Related Articles:
Scientists tout adult stem cell study results. Report
More doubts raised about embryonic stem cell project. Report
Mature stem cells prove effective in cloning. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: